19-6697818-G-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS1
The NM_000064.4(C3):c.2441-24C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000673 in 1,605,804 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.000033   (  0   hom.,  cov: 28) 
 Exomes 𝑓:  0.000071   (  0   hom.  ) 
Consequence
 C3
NM_000064.4 intron
NM_000064.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -4.54  
Publications
22 publications found 
Genes affected
 C3  (HGNC:1318):  (complement C3) Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015] 
C3 Gene-Disease associations (from GenCC):
- atypical hemolytic-uremic syndrome with C3 anomalyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
- complement component 3 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine
- C3 glomerulonephritisInheritance: AD Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84). 
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0000708 (103/1454236) while in subpopulation NFE AF = 0.000092 (102/1108944). AF 95% confidence interval is 0.0000771. There are 0 homozygotes in GnomAdExome4. There are 52 alleles in the male GnomAdExome4 subpopulation. Median coverage is 39. This position passed quality control check. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000330  AC: 5AN: 151568Hom.:  0  Cov.: 28 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
5
AN: 
151568
Hom.: 
Cov.: 
28
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000250  AC: 6AN: 239922 AF XY:  0.0000386   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
6
AN: 
239922
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000708  AC: 103AN: 1454236Hom.:  0  Cov.: 39 AF XY:  0.0000719  AC XY: 52AN XY: 722884 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
103
AN: 
1454236
Hom.: 
Cov.: 
39
 AF XY: 
AC XY: 
52
AN XY: 
722884
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33274
American (AMR) 
 AF: 
AC: 
0
AN: 
43674
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26014
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39482
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
85416
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52870
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
4512
European-Non Finnish (NFE) 
 AF: 
AC: 
102
AN: 
1108944
Other (OTH) 
 AF: 
AC: 
1
AN: 
60050
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.487 
Heterozygous variant carriers
 0 
 6 
 12 
 18 
 24 
 30 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000330  AC: 5AN: 151568Hom.:  0  Cov.: 28 AF XY:  0.0000405  AC XY: 3AN XY: 74002 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
5
AN: 
151568
Hom.: 
Cov.: 
28
 AF XY: 
AC XY: 
3
AN XY: 
74002
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41194
American (AMR) 
 AF: 
AC: 
0
AN: 
15210
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5152
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4808
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10530
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
5
AN: 
67902
Other (OTH) 
 AF: 
AC: 
0
AN: 
2078
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.545 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.